Breaking News Instant updates and real-time market news.

CL

Colgate-Palmolive

$68.84

(0.00%)

, BILI

Bilibili

$17.77

(0.00%)

09:40
04/25/19
04/25
09:40
04/25/19
09:40

Unusually active option classes on open April 25th

Unusual total active option classes on open include: Colgate Palmolive (CL), Bilibili (BILI), Yelp (YELP), iShares JP Morgan (EMB), Mondelez (MDLZ), Facebook (FB), Altria Group (MO), Marvell (MRVL), Chipotle (CMG), and Lam Research (LRCX).

CL

Colgate-Palmolive

$68.84

(0.00%)

BILI

Bilibili

$17.77

(0.00%)

YELP

Yelp

$38.03

(0.00%)

EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$109.43

(0.00%)

MDLZ

Mondelez

$50.40

(0.00%)

FB

Facebook

$182.64

(0.00%)

MO

Altria Group

$54.70

(0.00%)

MRVL

Marvell

$25.45

(0.00%)

CMG

Chipotle

$710.00

(0.00%)

LRCX

Lam Research

$195.40

(0.00%)

  • 25

    Apr

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 10

    May

  • 13

    May

  • 15

    May

  • 16

    May

  • 21

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

CL Colgate-Palmolive
$68.84

(0.00%)

03/29/19
UBSW
03/29/19
NO CHANGE
Target $75
UBSW
Buy
Colgate-Palmolive price target raised to $75 from $71 at UBS
UBS analyst Steven Strycula raised his price target on Colgate-Palmolive to $75 and kept his Buy rating. The analyst believes that the market "underappreciates" the company's ability to boost its prices over the long term. Strycula also anticipates Colgate-Palmolive to benefit as it "penetrates premium segments in developed markets and increases trade-up and brushing use in emerging markets," even as he sees its oral care portfolio "priced at a 12% value discount."
03/07/19
FBCO
03/07/19
INITIATION
FBCO
Credit Suisse starts Household Products & Beverages with Constellation top pick
Credit Suisse analyst Kaumil Gajrawala rolled out coverage last night on eight names in the Household Products & Beverages space. The analyst's ratings consist of three Outperforms, two Underperforms, and three Neutrals. His top pick is Constellation Brands (STZ), which he started with an Outperform rating and $230 price target. The company offers "predictable" high-single digit revenue growth with a valuation that is "well below slower growth peers," Gajrawala tells investors in a research note. His other Outperform ratings are on Monster Beverage (MNST) and Clorox (CLX). The analyst has a $78 price target on Monster, noting it is the fastest growing company in his coverage "with runway for continued growth." He has a $172 price target on Clorox saying the company's "unique" portfolio position justifies a premium valuation. Gajrawala's Neutral rated names are Church & Dwight (CHD), Procter & Gamble (PG) and Coca-Cola (KO). His two Underperforms are PepsiCo (PEP) and Colgate-Palmolive (CL). PepsiCo has a $100 price target as the analyst sees limited upside amid the company's "stepped-up" investment years. Colgate-Palmolive, Gajrawala's less favorite name, has a $55 price target. The company's out-year margins are at risk as it reinvests to address several years of slowing growth and sales declines, Gajrawala contends.
03/07/19
03/07/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Five Below (FIVE) initiated with an Outperform at Oppenheimer. 2. Teva (TEVA) reinstated with a Buy at UBS. 3. Chiasma (CHMA) initiated with an Overweight at Cantor Fitzgerald. 4. Monster Beverage (MNST) and Constellation Brands (STZ) were initiated with an Outperform at Credit Suisse, while Procter & Gamble (PG), Coca-Cola (KO), and Church & Dwight (CHD) were initiated with a Neutral, and PepsiCo (PEP), Colgate-Palmolive (CL), and Clorox (CLX) initiated with an Underperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/19
FBCO
03/06/19
INITIATION
Target $55
FBCO
Underperform
Colgate-Palmolive initiated with an Underperform at Credit Suisse
Credit Suisse started Colgate-Palmolive with an Underperform rating and $55 price target.
BILI Bilibili
$17.77

(0.00%)

04/10/19
UBSW
04/10/19
INITIATION
Target $23
UBSW
Buy
Bilibili initiated with a Buy at UBS
UBS analyst Angela Xu imitated Bilibili with a Buy and $23 price target saying it is uniquely positioned in terms of users and content among online video platforms. Its differentiated content and social features drive a sticky community of anime, comics and games fans and young users, who are highly willing to spend on content, the analyst wrote in a note to investors. Xu believes Bilibili remains in the early stages of monetization and over time has a high chance of developing multiple revenue growth driver than peers.
03/01/19
JPMS
03/01/19
DOWNGRADE
Target $20
JPMS
Neutral
Bilibili downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Alex Yao downgraded Bilibili to Neutral while raising his price target for the shares to $20 from $17. The analyst says that while the company's long-term value continues to rise, near-term expectations are now too high following Bilibili's Q4 results.
02/27/19
02/27/19
NO CHANGE

Bilibili reports Q4 EPS (7c), consensus (10c)
Reports Q4 revenue $168.1M, consensus $156.56M.
02/27/19
02/27/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Algonquin Power (AQN) initiated with a Neutral at BofA/Merrill. 2. Bilibili (BILI) initiated with a Buy at China Renaissance. 3. Livent (LTHM) initiated with a Buy at Gabelli. 4. Champions Oncology (CSBR) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
YELP Yelp
$38.03

(0.00%)

04/18/19
04/18/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with an Outperform at BMO Capital. 2. Ruth's Hospitality (RUTH) initiated with an Equal Weight at Stephens. 3. Conmed (CNMD) initiated with a Buy at Stifel. 4. Alcon (ALC) initiated with a Market Perform at BMO Capital. 5. Graham (GHM) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/19
BMOC
04/17/19
INITIATION
Target $45
BMOC
Outperform
Yelp initiated with an Outperform at BMO Capital
BMO Capital analyst Daniel Salmon initiated Yelp with an Outperform rating and a price target of $45. The analyst says the recent "investor skepticism around changes to Yelp's advertising business and the pull-back in shares provides an attractive entry point." Salmon contends that even though he does not expect the company to reach its FY23 targets, he sees revenue growth accelerating in 2019-2020 and supporting multiple expansion for the stock. The analyst adds that the risk-reward at current levels is skewed positively for Yelp shares.
04/17/19
BMOC
04/17/19
INITIATION
Target $45
BMOC
Outperform
Yelp initiated with an Outperform at BMO Capital
BMO Capital analyst Daniel Salmon initiated Yelp with an Outperform and $45 price target.
04/05/19
SBSH
04/05/19
NO CHANGE
Target $39
SBSH
Neutral
Citi lowers Yelp estimates below consensus, trims target to $39
Citi analyst Mark May lowered his estimates for Yelp below consensus saying the company's transition in its sales approach and recent introduction of lower-priced ad products creates near-term estimates risk. Further, Yelp's revenue growth could turn negative in Q2, May tells investors in a research note. The analyst lowered his price target for the shares to $39 from $40 and keeps a Neutral rating on Yelp. On the positive, however, the stock's valuation is low and near trough levels, says May. Moreover, recent activism could be a positive catalyst, including a potential acquisition or other operational improvements, the analyst writes.
EMB iShares JP Morgan USD Emerging Markets Bond ETF
$109.43

(0.00%)

MDLZ Mondelez
$50.40

(0.00%)

04/15/19
UBSW
04/15/19
NO CHANGE
Target $56
UBSW
Buy
Mondelez price target raised to $56 from $51 at UBS
UBS analyst Steven Strycula raised his price target on Mondelez (MDLZ) to $56 and kept his Buy rating, saying that while the stock has already outperformed the broader Consumer Staples ETF (XLP) by 14pts year-to-date, it can "rerate" further "if global organic sales trends grow over 2.5% and FY19 operating margin targets prove conservative." The analyst notes that while growth in U.S. food is scarce, he believes that Mondelez's relative price-to-earnings valuation can expand thanks to "relative sales outperformance and a pullback in rates."
01/23/19
01/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dell Technologies (DELL) initiated with a Buy at Citi. 2. General Mills (GIS) and Mondelez (MDLZ) were initiated with a Buy at Guggenheim, while Kraft Heinz (KHC) and Kellogg (K) were initiated with a Neutral, and J.M. Smucker (SJM) was initiated with a Sell. 3. BRT Apartments (BRT) initiated with a Neutral at Compass Point. 4. Atara Biotherapeutics (ATRA) initiated with a Buy at Mizuho. 5. Weyerhaeuser (WY) initiated with a Buy at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/24/19
BREN
01/24/19
DOWNGRADE
BREN
Hold
Mondelez downgraded to Hold from Buy at Berenberg
Berenberg analyst James Targett downgraded Mondelez to Hold after his analysis showed large brands trend to outperform, particularly in home care, hygiene and parts of personal care and packaged food.
01/24/19
01/24/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mondelez (MDLZ) downgraded to Hold from Buy at Berenberg. 2. Aratana (PETX) downgraded to Market Perform from Outperform at William Blair with analyst John Kreger saying in the last month the company disclosed two senior leadership departures while its activist investor disclosed a significant reduction in ownership. 3. Weibo (WB) downgraded to Hold from Buy at Jefferies with analyst Karen Chan saying Weibo remains an "irreplaceable" social media platform in China and mobile game approval resumption could be a catalyst, but the macro impact on handset, auto and entertainment could weigh on the company's overall advertising growth. 4. Mindbody (MB) downgraded to Market Perform from Outperform at JMP Securities with analyst Patrick Walravens citing the expiration of the 30-day go-shop period contained in the merger agreement with Vista Equity Partners. At this point, he thinks it seems unlikely that Mindbody will receive a superior proposal. 5. Canada Goose (GOOS) downgraded to Market Perform from Outperform at Wells Fargo with analyst Ike Boruchow saying while he remains confident on the trajectory of the Canada Goose brand and the fundamental story that has developed since their IPO in 2017, he feels the risk/reward is not as compelling as it once was. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FB Facebook
$182.64

(0.00%)

04/25/19
JEFF
04/25/19
NO CHANGE
Target $230
JEFF
Buy
Facebook price target raised to $230 from $200 at Jefferies
Jefferies analyst Brent Thill raised his price target for Facebook to $230 from $200 saying last night's "beat quarter" proves the company can sustainably grow its organic business while also investing for longer term initiatives. Facebook surprised with lower than anticipated operating expenditure growth of 39%, says the analyst, whose initial estimate was 50%. Better than expected marketing spend and lower than expected hiring contributed to the beat and should also help with lower than anticipated expense growth throughout 2019, Thill tells investors in a post-earnings research note titled "Better Friend Than You Thought." He sees upside in 2019 and 2020 from Instagram through better Stories monetization and new initiatives in commerce. The analyst keeps a Buy rating on Facebook.
04/25/19
BMOC
04/25/19
NO CHANGE
Target $200
BMOC
Market Perform
Facebook price target raised to $200 from $190 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Facebook to $200 and also raised his FY19 EPS view to $7.76 from $7.41 after its better than expected Q1 results, noting that the management reduced its outlook for operating expense in 2019. The analyst is keeping his Market Perform rating on Facebook shares however, forecasting the company's revenue deceleration to bottom in Q4 of this year before an upward inflection in Q1 on ramping Stories demand. Salmon adds that despite the "regulatory overhang", he remains on the "positive side" of his rating as the stock price has reflected his "more cautious view on margins".
04/25/19
OPCO
04/25/19
NO CHANGE
Target $225
OPCO
Outperform
Facebook price target raised to $225 from $195 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Facebook to $225 from $195 after the company reported modestly better revenue, but meaningfully lower Q1 core opex, and lowered fiscal year core expense guidance. While changes to ad policies for certain categories and deployment of new consumer privacy features will reduce the second half ad targeting effectiveness, the analyst still sees revenues 22%-plus in Q4. Helfstein reiterates an Outperform rating on the shares.
04/25/19
FBCO
04/25/19
NO CHANGE
Target $235
FBCO
Outperform
Facebook price target raised to $235 from $211 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Facebook to $235 from $211 saying that after a year of controversy, he welcomes a straightforward quarter, as ad revenue grew 31%-plus on an FX Neutral basis driven by ongoing pricing and monetization strength on both core Facebook and Instagram. The analyst reiterates an Outperform rating on the shares.
MO Altria Group
$54.70

(0.00%)

03/06/19
MSCO
03/06/19
NO CHANGE
MSCO
Resignation of Gottlieb lowers near-term overhang on Altria, says Morgan Stanley
Morgan Stanley analyst Pamela Kaufman said she expects a positive reaction in tobacco stocks to the news that FDA Commissioner Scott Gottlieb will resign in April as it likely delays the agency's near-term tobacco control objectives. Gottlieb has been very vocal on tobacco regulation and his resignation creates a vacuum in leadership and uncertainty about the agency's strategy for tobacco control until a new head is appointed, though leadership at the Center of Tobacco Products remains intact under Mitch Zeller, Kaufman tells investors. While his resignation reduces the near-term regulatory overhang on Altria (MO), it could be a "mixed bag for e-cigs," as Gottlieb changed his tone last year due to the youth e-cig epidemic but he had previously increased leniency towards the category when he pushed out the PMTA deadline to 2022 from 2018, added Kaufman.
03/06/19
JEFF
03/06/19
NO CHANGE
JEFF
Gottlieb resignation positive for tobacco sentiment, says Jefferies
The resignation of FDA commissioner Scott Gottlieb is a net positive for tobacco sentiment, particularly for British American Tobacco (BTI) as it should lessen concerns related to any possible action around a menthol ban near term, Jefferies analyst Owen Bennett tells investors in a research note. A potential delay to guidelines around e-vapour restrictions could also support both British American and Imperial Brands (IMBBY), adds the analyst.
03/05/19
COWN
03/05/19
INITIATION
COWN
Market Perform
Cronos Group initiated with a Market Perform at Cowen
Cowen analyst Vivien Azer started Cronos Group (CRON) with a Market Perform rating and C$29 price target. The analyst likes the company's story as an asset-light, global low-cost producer with operational support and invested capital from Altria Group (MO). However, Azer says the stock's current valuation prevents her from taking a more constructive position at this time.
02/25/19
JEFF
02/25/19
INITIATION
JEFF
Underperform
Cronos Group initiated with an Underperform at Jefferies
Jefferies analyst Owen Bennett initiated coverage of nine cannabis stocks, stating that his base-case "conservative" assumption is that the cannabis industry can grow in size to over $50B by 2029 from $17B in 2019. He started Cronos Group (CRON) with an Underperform rating and C$17 price target, stating that "at present we feel there is little to get really excited about other than the investment and large sum of money" from Altria (MO). He thinks "the market has gotten ahead of itself" on Cronos as he questions when Altria value creation will begin to materialize, Bennett tells investors.
MRVL Marvell
$25.45

(0.00%)

03/08/19
CHLM
03/08/19
NO CHANGE
Target $19
CHLM
Hold
Marvell shares fully valued at current levels, says Craig-Hallum
Craig-Hallum analyst Christian Schwab maintained a Hold rating and $19 price target on Marvell following the company's Q4 results, telling investors in a research note that FY20 is set to be a challenging year, albeit with an expected bottom in Q1 and improvement through the course of the year. Schwab does believe the company is well positioned with growth prospects in both 5G and automotive, but believes shares remain fully valued at current levels until he sees more tangible traction of the company's growth prospects.
04/24/19
UBSW
04/24/19
NO CHANGE
Target $29
UBSW
Buy
Marvell price target raised to $29 from $22 at UBS
UBS analyst Timothy Arcuri raised his price target on Marvell to $29 and kept his Buy rating, citing its position on the infrastructure side as 5G becomes a "more palpable investor theme." The analyst further notes that the buildout remains in its "very early innings", estimating about $1B in incremental revenue from 5G technology starting in 2020 and extending through 2023-24.
03/29/19
MZHO
03/29/19
NO CHANGE
Target $140
MZHO
Buy
Xilinx price target raised to $140 from $107 at Mizuho
Mizuho analyst Vijay Rakesh raised his price target for Xilinx (XLNX) to $140 from $107 following his trip to Asia and channel checks with the supply chain. Xilinx is a "significant leader" in 5G, with orders potentially up 50%-plus year-over-year in 2019 as the company is getting ~95% of 5G orders, Rakesh tells investors in a research note. The analyst also believes Xilinx has a "strong lead" over Intel (INTC) and Marvell Technology (MRVL). He reiterates a Buy rating on the shares.
04/17/19
SBSH
04/17/19
NO CHANGE
Target $28
SBSH
Buy
Marvell price target raised to $28 from $22 at Citi
Citi analyst Atif Malik raised his price target for Marvell Technology Group to $28 from $22 citing improving storage fundamentals, increasing confidence in 5G momentum, and the company's "growing M&A appeal." Marvell is the best way of playing the "second wave" of 5G cycle spend as carriers' start to move to ASIC late this year, Malik tells investors in a research note. He keeps a Buy rating on the shares.
CMG Chipotle
$710.00

(0.00%)

04/25/19
CHLM
04/25/19
NO CHANGE
Target $125
CHLM
Buy
PayPal price target raised to $125 from $110 at Craig-Hallum
Craig-Hallum analyst Bradley Berning raised his price target for PayPal (PYPL) to $125 form $110 as network effects continue to pay dividends, driving a slight beat despite headwinds from FX and eBay (EBAY). Additional Venmo metrics such as revenue run rate commentary ahead of expectations, active user color and successful Venmo use case adding 1M Chipotle (CMG) rewards customer sign ups in a week should help investors' confidence in the company's ability to monetize the user base, he contends. The analyst reiterates a Buy rating on PayPal's shares.
04/25/19
LOOP
04/25/19
NO CHANGE
Target $780
LOOP
Buy
Chipotle price target raised to $780 from $630 at Loop Capital
Loop Capital analyst Lynne Collier raised her price target on Chipotle to $780 and kept her Buy rating after its Q1 earnings beat and a 9.9% increase in comps that topped consensus of 7.8%. The analyst also notes the company's restaurant-level margins coming at 190bps above her forecast at the highest level in 4 years. Collier believes that in spite of the 64% year-to-date gains in Chipotle stock price, the company remains in the "early stages of a multi-year turnaround."
04/25/19
WEDB
04/25/19
NO CHANGE
Target $700
WEDB
Neutral
Chipotle price target raised to $700 from $680 at Wedbush
Wedbush analyst Nick Setyan raised his price target for Chipotle to $700 from $680 given Q1 EPS and same-store sales growth higher than consensus, but largely in-line with buy-side expectations. The analyst reiterates a Neutral rating on the shares as he believes current valuation appropriately reflects investor expectations through 2020.
LRCX Lam Research
$195.40

(0.00%)

04/23/19
NEED
04/23/19
NO CHANGE
Target $215
NEED
Buy
Lam Research, Applied Materials price targets raised at Needham
Needham analyst N. Quinn Bolton raised his price target on Buy-rated Lam Research (LRCX) to $215 from $180 and Applied Materials (AMAT) to $52 from $45 as part of his broader industry research note on semiconductor names. The analyst states that while the WFE trough is likely to be prolonged with capital expenditures falling by 19% in 2019, he sees investors "largely looking past near-term results with an eye towards a spending recovery in 2020 and beyond." Bolton recommends that investors use any near-term earnings-driven weakness in Lam Research and Applied Materials as a buying opportunity.
04/25/19
KEYB
04/25/19
NO CHANGE
Target $236
KEYB
Overweight
Lam Research price target raised to $236 from $226 at KeyBanc
KeyBanc analyst Weston Twigg raised his price target for Lam Research to $236 from $223 after the company posted a "solid" Q3 beat and guided Q4 moderately above consensus, and as he sees compelling EPS upside potential. The analyst reiterates an Overweight rating on the shares.
04/25/19
SBSH
04/25/19
NO CHANGE
Target $224
SBSH
Buy
Citi ups target on top equipment pick Lam Research to $224
Citi analyst Atif Malik raised his price target for Lam Research to $224 from $215 following the company's "beat and raise" earnings report. The stock typically outperforms the group out of a memory downturn, Malik tells investors in a research note. He says Lam remains his top pick equipment pick with a Buy rating. While Lam continues to expect the DRAM spending correction to last through the end of the year, bit shipments in NAND in the month of February were above seasonal and market conditions are setting up for a recovery of supply/demand balance, contends Malik.
04/23/19
RBCM
04/23/19
NO CHANGE
Target $220
RBCM
Outperform
Lam Research price target raised to $220 from $190 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on Lam Research to $220 and kept his Outperform rating ahead of its Q3 earnings, saying that while the near-term results may be a "tad light" given the latest Micron (MU) print and guide, investors will likely focus on the commentary around second-half of 2019 demand trends. The analyst believes that a below-consensus Q3 earnings print may not move the stock lower "materially" if the management conveys expectations of a second-half improvement or if Lam Research guides Q4 EPS above $3.25 per share.

TODAY'S FREE FLY STORIES

SCHW

Charles Schwab

$40.40

0.38 (0.95%)

15:06
07/15/19
07/15
15:06
07/15/19
15:06
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

FB

Facebook

$204.99

0.085 (0.04%)

, GOOG

Alphabet

$1,147.08

2.53 (0.22%)

15:04
07/15/19
07/15
15:04
07/15/19
15:04
Periodicals
Facebook hires former Vine chief to its new experimental app division, Verge say »

Chaim Gartenberg of the…

FB

Facebook

$204.99

0.085 (0.04%)

GOOG

Alphabet

$1,147.08

2.53 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

WTFC

Wintrust Financial

$70.39

-1.65 (-2.29%)

15:04
07/15/19
07/15
15:04
07/15/19
15:04
Options
Wintrust Financial options imply 4.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 06

    Aug

GLPG

Galapagos

$169.98

24.31 (16.69%)

, GILD

Gilead

$68.00

1.75 (2.64%)

14:56
07/15/19
07/15
14:56
07/15/19
14:56
Downgrade
Galapagos, Gilead rating change  »

Galapagos downgraded to…

GLPG

Galapagos

$169.98

24.31 (16.69%)

GILD

Gilead

$68.00

1.75 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

JPM

JPMorgan

$114.02

-1.3 (-1.13%)

, JNJ

Johnson & Johnson

$134.89

0.6 (0.45%)

14:53
07/15/19
07/15
14:53
07/15/19
14:53
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JPM

JPMorgan

$114.02

-1.3 (-1.13%)

JNJ

Johnson & Johnson

$134.89

0.6 (0.45%)

WFC

Wells Fargo

$46.66

-0.69 (-1.46%)

GS

Goldman Sachs

$211.67

-2.28 (-1.07%)

PLD

Prologis

$80.11

0.08 (0.10%)

FRC

First Republic

$98.89

-1.74 (-1.73%)

DPZ

Domino's Pizza

$269.81

-12.42 (-4.40%)

SNV

Synovus

$34.65

-0.78 (-2.20%)

FHN

First Horizon

$14.89

-0.22 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 29

    Jul

  • 30

    Jul

  • 06

    Aug

  • 27

    Aug

  • 28

    Aug

  • 06

    Sep

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 12

    Oct

  • 13

    Nov

JBHT

J.B. Hunt

$92.62

-0.33 (-0.36%)

14:52
07/15/19
07/15
14:52
07/15/19
14:52
Earnings
Notable companies reporting after market close »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 26

    Aug

  • 13

    Nov

JBHT

J.B. Hunt

$92.62

-0.33 (-0.36%)

14:49
07/15/19
07/15
14:49
07/15/19
14:49
Options
J B Hunt Transport Services options imply 7.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 26

    Aug

  • 13

    Nov

AGRX

Agile Therapeutics

$1.30

0.01 (0.78%)

14:48
07/15/19
07/15
14:48
07/15/19
14:48
Recommendations
Agile Therapeutics analyst commentary at Oppenheimer »

FDA guidance looks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$41.82

0.575 (1.39%)

14:45
07/15/19
07/15
14:45
07/15/19
14:45
Options
Taiwan Semi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ALTR

Altair

$41.54

0.37 (0.90%)

14:37
07/15/19
07/15
14:37
07/15/19
14:37
Hot Stocks
Altair beneficial owner George Christ sells $1.5M in company shares »

Altair beneficial owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$211.82

-2.13 (-1.00%)

, BAC

Bank of America

$29.19

-0.25 (-0.85%)

14:36
07/15/19
07/15
14:36
07/15/19
14:36
Earnings
Fly Intel: What to watch in next round of big banks' earnings reports »

Goldman Sachs (GS), Bank…

GS

Goldman Sachs

$211.82

-2.13 (-1.00%)

BAC

Bank of America

$29.19

-0.25 (-0.85%)

MS

Morgan Stanley

$44.60

-0.27 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 06

    Aug

  • 06

    Sep

AMBA

Ambarella

$46.20

-0.06 (-0.13%)

14:35
07/15/19
07/15
14:35
07/15/19
14:35
Options
Ambarella put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$300.59

-0.09 (-0.03%)

, SPX

S&P 500

$0.00

(0.00%)

14:29
07/15/19
07/15
14:29
07/15/19
14:29
General news
Mnuchin said he thinks a budget deal is 'close' »

Treasury Secretary Steve…

SPY

SPDR S&P 500 ETF Trust

$300.59

-0.09 (-0.03%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$300.57

-0.11 (-0.04%)

, SPX

S&P 500

$0.00

(0.00%)

14:27
07/15/19
07/15
14:27
07/15/19
14:27
General news
Mnuchin says had 'very productive' talks with Pelosi on debt ceiling »

Treasury Secretary Steve…

SPY

SPDR S&P 500 ETF Trust

$300.57

-0.11 (-0.04%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$12.55

0.41 (3.38%)

14:26
07/15/19
07/15
14:26
07/15/19
14:26
Conference/Events
LogicBio Therapeutics management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

QURE

uniQure

$68.66

-1.74 (-2.47%)

14:25
07/15/19
07/15
14:25
07/15/19
14:25
Options
uniQure call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

AVGO

Broadcom

$290.65

5.26 (1.84%)

, SYMC

Symantec

$21.78

-3.78 (-14.79%)

14:21
07/15/19
07/15
14:21
07/15/19
14:21
Periodicals
Broadcom still keen to find solution as Symantec bid stalls over price, FT says »

Broadcom's (AVGO)…

AVGO

Broadcom

$290.65

5.26 (1.84%)

SYMC

Symantec

$21.78

-3.78 (-14.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
07/15/19
07/15
14:17
07/15/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/15/19
07/15
14:16
07/15/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$26.49

-0.32 (-1.19%)

14:15
07/15/19
07/15
14:15
07/15/19
14:15
Options
KKR put volume heavy and directionally bearish »

Bearish flow noted in KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

14:15
07/15/19
07/15
14:15
07/15/19
14:15
General news
Fed funds futures are fractionally higher »

Fed funds futures are…

FB

Facebook

$203.96

-0.945 (-0.46%)

, BTC

Bitcoin

$0.00

(0.00%)

14:14
07/15/19
07/15
14:14
07/15/19
14:14
Hot Stocks
Mnuchin says Trump has cryptocurrency concerns, won't target a specific provider »

Asked about President…

FB

Facebook

$203.96

-0.945 (-0.46%)

BTC

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

C

Citi

$71.87

0.12 (0.17%)

14:11
07/15/19
07/15
14:11
07/15/19
14:11
Hot Stocks
Citi reports June credit loss rate 2.56% vs. 2.74% last month »

Reports June 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

  • 13

    Aug

FB

Facebook

$203.77

-1.135 (-0.55%)

14:09
07/15/19
07/15
14:09
07/15/19
14:09
Hot Stocks
Breaking Hot Stocks news story on Facebook »

Mnuchin says Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

FB

Facebook

$203.81

-1.095 (-0.53%)

, BTC

Bitcoin

$0.00

(0.00%)

14:07
07/15/19
07/15
14:07
07/15/19
14:07
Hot Stocks
Mnuchin says Treasury has 'serious concerns' about Facebook's Libra, bitcoin »

Treasury Secretary Steven…

FB

Facebook

$203.81

-1.095 (-0.53%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.